Opportunity Information: Apply for PAR 15 155
Apply for PAR 15 155
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.397 Cancer Centers Support Grants 93.398 Cancer Research Manpower.
- This funding opportunity was created on Mar 26, 2015 and posted on Mar 26, 2015.
- Applicants must submit their applications by Jun 8, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,300,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Independent school districts City or township governments Private institutions of higher education Public housing authorities/Indian housing authorities Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments County governments Public and State controlled institutions of higher education Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (PAR-15-155) is an NIH National Cancer Institute (NCI) administrative supplement program designed to expand cancer prevention and control (CPC) research partnerships between NCI-designated cancer centers in the United States and collaborating institutions located in low- and middle-income countries (LMICs), using the World Bank definition of LMIC status. Rather than funding entirely new standalone projects, the program provides add-on funds (administrative supplements) to cancer centers that already hold active P30 Cancer Center Support Grants. The intent is to help these centers launch or deepen pilot-scale CPC research activities that are jointly planned and carried out with LMIC partners, building the foundation for longer-term, externally funded collaborations.
A central goal of the supplements is to stimulate sustainable research programs that directly address cancer prevention, early detection, diagnosis-related pathways, and broader control strategies in settings where cancer burden is rising and resources can be limited. NCI, through its Center for Global Health (CGH), emphasizes that funded pilots should be locally relevant and responsive to the needs of multiple stakeholders. In practical terms, applicants are expected to frame research questions that matter not only to the academic investigators involved, but also to local ministries or health departments and to community members who are affected by cancer risks, screening barriers, access challenges, and treatment follow-up. The program is structured so that the work produces direct local benefit in the LMIC setting, while also generating findings that could inform cancer prevention and control approaches in the U.S. and other countries.
The anticipated outcome is that these pilot projects will mature into larger, competitively funded collaborative grants that formally link investigators at NCI-designated cancer centers with investigators and institutions in LMICs. In other words, the supplement is meant to be catalytic: it provides targeted support to generate preliminary data, test implementation strategies, establish research infrastructure or procedures, and strengthen partnership operations so teams are well-positioned to pursue future multi-year research funding.
From an administrative standpoint, this is a discretionary grant program with an education/health activity focus, posted March 26, 2015, with an application closing date of June 8, 2015, and an archive date of July 9, 2015. NCI expected to make about 10 awards, with an estimated total funding level of $1.3 million across awards. There is no cost-sharing or matching requirement indicated. The related CFDA program areas span cancer causes and prevention research (93.393), cancer detection and diagnosis research (93.394), cancer centers support grants (93.397), and cancer research manpower (93.398), reflecting the program's alignment with both research generation and capacity-building within cancer center networks.
Eligibility is centered on currently funded P30 NCI-designated cancer center grantees, since the mechanism is an administrative supplement to an existing award. While the general eligibility list in the source data includes many U.S.-based organization types (state and local governments, nonprofits, universities, small businesses, tribal entities, and others), the practical takeaway is that the applicant must be an eligible U.S. entity holding the active P30 award. Non-U.S. (foreign) institutions are not eligible to apply as the primary applicant, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined under NIH policy, are allowed, which is consistent with the program's design: U.S. cancer centers apply for the supplement while working in close partnership with LMIC institutions that participate in the research.
Overall, PAR-15-155 is best understood as a targeted NCI investment in global cancer prevention and control collaboration. It uses a relatively fast, pilot-oriented supplement approach to strengthen partnerships, generate locally useful evidence, and position U.S.-LMIC teams to compete for larger collaborative research grants that can meaningfully improve cancer prevention and control strategies across diverse settings.
Frequently Asked Questions (FAQs) - NIH/NCI Administrative Supplement PAR-15-155
What is PAR-15-155?
PAR-15-155 is an NIH National Cancer Institute (NCI) administrative supplement opportunity designed to expand cancer prevention and control (CPC) research partnerships between NCI-designated cancer centers in the United States and collaborating institutions in low- and middle-income countries (LMICs).
Is this funding for brand-new standalone projects?
No. This opportunity provides administrative supplements (add-on funds) to support pilot-scale CPC research activities under an existing grant. It is not intended to fund entirely new, independent projects separate from an existing award.
What existing grant must an applicant already have to be eligible?
The applicant must be a currently funded NCI-designated cancer center grantee holding an active P30 Cancer Center Support Grant, since the supplement is added to that existing award.
Who can apply as the primary applicant organization?
The practical requirement is that the primary applicant must be an eligible U.S. entity that holds the active P30 award. While general eligibility categories may list many U.S. organization types, this supplement is specifically tied to the P30 Cancer Center Support Grant mechanism.
Can a foreign (non-U.S.) institution apply as the primary applicant?
No. Non-U.S. (foreign) institutions are not eligible to apply as the primary applicant for this supplement.
Are non-domestic components of U.S. organizations eligible to apply?
No. Non-domestic components of U.S. organizations are not eligible to apply as the primary applicant.
Are foreign components allowed in the project?
Yes. Foreign components, as defined under NIH policy, are allowed. This aligns with the program design in which U.S. cancer centers apply for the supplement while working closely with LMIC partner institutions that participate in the research.
What types of research does the program aim to support?
The program aims to support pilot-scale cancer prevention and control research that can include cancer prevention, early detection, diagnosis-related pathways, and broader cancer control strategies, particularly in settings where cancer burden is rising and resources may be limited.
What is the purpose of focusing on LMIC partners?
The purpose is to expand and strengthen collaborative CPC research partnerships with institutions in LMICs, where cancer burden is increasing and prevention and control strategies can have significant impact.
How is LMIC status determined for this program?
LMIC status is based on the World Bank definition of low- and middle-income countries, as referenced in the opportunity description.
What does NCI expect in terms of local relevance and stakeholder needs?
NCI emphasizes that funded pilots should be locally relevant and responsive to the needs of multiple stakeholders. Research questions are expected to matter not only to academic investigators but also to local ministries or health departments and to community members affected by cancer risks, screening barriers, access challenges, and follow-up issues.
Does the project need to produce benefits in the LMIC setting?
Yes. The program is structured so the work produces direct local benefit in the LMIC setting, while also generating findings that may inform cancer prevention and control approaches in the U.S. and other countries.
What is the intended long-term outcome of these supplements?
The supplements are intended to be catalytic, helping pilot projects mature into larger, competitively funded collaborative grants that formally link investigators at NCI-designated cancer centers with investigators and institutions in LMICs.
What kinds of activities can the supplement help support (in general terms)?
Based on the opportunity description, the supplement can support efforts such as generating preliminary data, testing implementation strategies, establishing research infrastructure or procedures, and strengthening partnership operations so teams are positioned to pursue future multi-year research funding.
How many awards were expected to be made?
NCI expected to make about 10 awards under this opportunity.
What was the estimated total funding level?
The estimated total funding level across awards was $1.3 million.
Is there a cost-sharing or matching requirement?
No cost-sharing or matching requirement is indicated in the provided information.
What type of program is this described as (administratively)?
It is described as a discretionary grant program with an education/health activity focus.
When was this opportunity posted, and what were the key dates?
The opportunity was posted on March 26, 2015. The application closing date was June 8, 2015, and the archive date was July 9, 2015.
What CFDA program areas are associated with this opportunity?
The related CFDA program areas span cancer causes and prevention research (93.393), cancer detection and diagnosis research (93.394), cancer centers support grants (93.397), and cancer research manpower (93.398).
Why does the opportunity reference multiple CFDA areas?
The CFDA areas reflect the program's alignment with both research generation (prevention, detection, diagnosis) and capacity-building within cancer center networks (support grants and manpower).
What is the role of the NCI Center for Global Health (CGH) in this opportunity?
NCI, through its Center for Global Health (CGH), emphasizes that pilot projects should be locally relevant and responsive to stakeholder needs, consistent with the global collaboration focus of the supplements.
In plain terms, what is this opportunity trying to accomplish?
It is a targeted NCI investment to quickly strengthen U.S.-LMIC cancer prevention and control collaborations through pilot-oriented add-on funding, producing locally useful evidence and positioning teams to compete for larger collaborative research grants.
Browse more opportunities from the same category: Education Health
Next opportunity: Energy and Mineral Development Grants
Previous opportunity: Alaska Native Serving and Native Hawaiian Serving Institutions Education Competitive Grants Program (ANNH)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 155
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 155) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research Answers to NCIs Provocative Questions (R21) Apply for RFA CA 15 009 Funding Number: RFA CA 15 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions (R01) Apply for RFA CA 15 008 Funding Number: RFA CA 15 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Regional Medical Libraries for the National Network of Libraries of Medicine (UG4) Apply for RFA LM 15 003 Funding Number: RFA LM 15 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Apply for PA 15 177 Funding Number: PA 15 177 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34) Apply for PA 15 250 Funding Number: PA 15 250 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) Apply for PA 15 251 Funding Number: PA 15 251 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03) Apply for PA 15 252 Funding Number: PA 15 252 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Apply for PA 15 253 Funding Number: PA 15 253 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Development of Measures of Fatigability in Older Adults (R21) Apply for RFA AG 16 013 Funding Number: RFA AG 16 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Provocative Questions in Cancer with an Underlying HIV Infection (R21) Apply for RFA CA 15 013 Funding Number: RFA CA 15 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Provocative Questions (PQ) Initiative Cancer with an Underlying HIV Infection (R01) Apply for RFA CA 15 012 Funding Number: RFA CA 15 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers (RICs)(U24) Apply for RFA TR 15 004 Funding Number: RFA TR 15 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (Admin Supp) Apply for PA 15 264 Funding Number: PA 15 264 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Martin Delaney Collaboratories for HIV Cure Research (UM1) Apply for RFA AI 15 029 Funding Number: RFA AI 15 029 Agency: National Institutes of Health Category: Education Health Funding Amount: $3,500,000 |
| Oncology Co Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) Apply for PAR 15 266 Funding Number: PAR 15 266 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Fast Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3) Apply for PAR 15 267 Funding Number: PAR 15 267 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Harnessing Genome Editing Technologies to Functionally Validate Genetic Variants in Substance Use Disorders (R21/R33) Apply for RFA DA 16 004 Funding Number: RFA DA 16 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools and Services for Designing Methodologically Rigorous Animal Studies (R41/R42) Apply for RFA DA 16 002 Funding Number: RFA DA 16 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Tools and Services for Designing Methodologically Rigorous Animal Studies (R43/R44) Apply for RFA DA 16 003 Funding Number: RFA DA 16 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Career Development Program in Emergency Care Research (K12) Apply for RFA HL 16 019 Funding Number: RFA HL 16 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 155", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.